Muscular Dystrophy Resource Tools
We’re excited to introduce these valuable tools and resources, designed to empower and inform those navigating the challenges of Muscular Dystrophy. Stay tuned to see how ACTION is working to …
We’re excited to introduce these valuable tools and resources, designed to empower and inform those navigating the challenges of Muscular Dystrophy. Stay tuned to see how ACTION is working to …
ACTION, in conjunction with Berlin Heart, Inc., launched the first prospective FDA regulated device trial using a pediatric ventricular assist device (VAD) registry in November 2022. Enrollment in the trial has been completed as of August 11, 2023, just 10 months after launch.
ACTION is proud to release our newest education material for patients and caregivers for the HVAD™ System.
Prompted by needs and interests of our Families in ACTION (FACT) Committee, ACTION recently joined forces with a fellow Cardiac Networks United organization, the Cardiac Neurodevelopmental Outcome Collaborative to: develop patient …
Hearts & Minds: Neurodevelopment in Pediatric Heart Failure and VAD Patients Read More »
Check out ACTION’s Pediatric Heart Failure Toolkit. Download patient and care team friendly handouts below. Providers For more tools, including a Heart Failure Daily Communication Checklist and a Heart Failure Discharge Plan login …
Our new Strategic Plan details our current goals and highlights some of our future initiatives. Download our 2022 Strategic Plan PDF and check out everything we are working toward. Thank …
We have exciting news to share! ACTION has joined forces with OmniLife! Please see the OmniLife press release below or check out the full Business Wire press release here. LEXINGTON, …
OmniLife and ACTION Network Solidify Collaboration to Drive Innovation Read More »
ACTION is proud to release our newest education material for patients and caregivers for the HVAD™ System.
The year 2020 definitely had it’s challenges, but ACTION didn’t slow down. Check out all our accomplishments and learnings from the last year below. 2020 Highlights Report 2020 Data Report
ACTION centers collaborate with Abbott to update FDA labeling of the HeartMate 3™ LVAD for use in pediatrics CINCINNATI — The FDA has updated Abbott’s HeartMate 3™ LVAD labeling to treat children …